Home Cart Sign in  
Chemical Structure| 309-29-5 Chemical Structure| 309-29-5

Structure of Doxapram
CAS No.: 309-29-5

Chemical Structure| 309-29-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Doxapram inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Doxapram

CAS No. :309-29-5
Formula : C24H30N2O2
M.W : 378.51
SMILES Code : O=C1N(CC)CC(CCN2CCOCC2)C1(C3=CC=CC=C3)C4=CC=CC=C4
MDL No. :MFCD00242721

Safety of Doxapram

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01022151 Anaesthesia Phase 2 Completed - Saudi Arabia ... More >> King Faisal University Khobar, Eastern, Saudi Arabia, 31952 Less <<
NCT01344317 - Unknown June 2016 Austria ... More >> Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Neonatology Vienna, Austria, 1090 Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT02421068 - Completed - Netherlands ... More >> MUMC Maastricht, Netherlands, 6229 HX Radboud UMC Nijmegen, Netherlands, 6525 GA Erasmus MC - Sophia Children's Hospital Rotterdam, Netherlands, 3015 CN Maxima Medical Center Veldhoven, Netherlands, 5504 DB Less <<
NCT00477451 Treatment of Induced Panic Att... More >>ack Less << Phase 2 Completed - United States, New York ... More >> SUNY Downstate Medical Center Brooklyn, New York, United States, 11203-2056 New York State Psychiatric Institute New York, New York, United States, 10021 Mt. Sinai School Of Medicine New York, New York, United States, 10029 Less <<
NCT02820025 Anesthesia Not Applicable Active, not recruiting December 2017 China, Ningxia ... More >> Anesthesiology department of General Hospital of Ningxia Medical University Yinchuan, Ningxia, China, 750004 Less <<
NCT00477451 - Completed - -
NCT02171910 Sedation Hypo... More >>xia Less << Phase 4 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Uusimaa, Finland, 00029 HUS Less <<
NCT00389909 Premature Infants ... More >> Apnea Less << Phase 4 Completed - France ... More >> Maternite Regionale Universitaire Nancy, France, 54042 Hopital des Enfants Toulouse, France, 31059 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.64mL

0.53mL

0.26mL

13.21mL

2.64mL

1.32mL

26.42mL

5.28mL

2.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories